One pre-clinical research study observed that chronic AR activation, through testosterone-BSA exposure, enhanced paclitaxel microtubule disrupting dynamics, inhibited cell proliferation, and induced apoptosis in androgen sensitive and insensitive human prostate cancer cell lines [140]. This evidence concerns the gene AR and prostate carcinoma.